IRVING, Bryan,CHEUNG, Jeanne,CHIU, Henry,LEHAR, Sophie M.,MAECKER, Heather,MARIATHASAN, Sanjeev,WU, Yan
申请号：
AU2020204593
公开号：
AU2020204593A1
申请日:
2020.07.09
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020204593A120200730.pdf#####Abstract of the Disclosure The present application relates to anti-PD-Li antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., 5 acute and chronic) and tumor immunity. 13101473_1 (GHMatters) P86802.AU.31/17 0 c0 . t t 0 co k ) a I0 0 co o c CAo 0. CL.0
